1180 Life Sciences Corp. is a biotech company developing treatments for chronic pain, inflammation, and fibrosis. They have several product development platforms, including fibrosis and anti-TNF, synthetic CBD analogs, and a7nAChR. The company is based in Palo Alto, California, and was founded in 2016.